Amesite Inc Stock Price, News & Analysis

Amesite (NASDAQ: AMST) reported a 69% quarter-over-quarter revenue increase in Q2 2026 while reducing spending and expanding customers in post-acute healthcare. The company cited 82% and 69% QoQ revenue gains across the last two quarters, rising customer adoption of its NurseMagic™ AI platform, and high engagement with 6,500 daily explainer-video views and 28,000 daily website visitors. Amesite plans to launch what it describes as the first AI-powered EMR for post-acute care by 2026 and emphasized continued AI-driven product rollouts and operational discipline.

Amesite (NASDAQ: AMST), an AI-powered enterprise solutions developer, reported 63% revenue growth for its NurseMagic™ platform following the July 14, 2025 launch of its census-based Enterprise subscription model. The company announced that Enterprise sales have surpassed B2C sales, driven by post-acute care providers seeking scalable compliance solutions.

Amesite also launched an AI-powered automated form fill solution for government forms, specifically targeting the upcoming Centers for Medicare & Medicaid Services (CMS) mandate for Hospice Outcomes and Patient Evaluation (HOPE) assessment. The solution aims to help healthcare organizations auto-populate complex forms, reduce administrative time, and ensure full reimbursements in a market growing at a CAGR of 8%.

Amesite (NASDAQ: AMST) has launched NurseMagic™ Enterprise Tier, an advanced AI-powered solution for post-acute healthcare providers. The new tier introduces three key features: seamless EMR integration with bi-directional data transfer, automated interdisciplinary team (IDT) reporting, and custom-formatted documentation support.

A significant change in the business model introduces census-based pricing, aligning costs with patient numbers rather than staff count. This strategic shift aims to facilitate enterprise-wide adoption and scalable revenue growth. The company will discontinue new sales of its entry-level B2B Teams plan, focusing on Teams Plus+ for smaller organizations and the new Enterprise Tier for larger-scale deployments.

Amesite (NASDAQ: AMST) has announced a significant expansion of its NurseMagic™ V3.0 app, now supporting 16 languages to serve nearly 1 million U.S. nurses who speak English as a second language (19.2% of nursing workforce). The HIPAA-compliant AI-powered charting solution targets both domestic ESL nurses and international healthcare markets, including the 6.5 million nurses in top medical tourism destinations.

The company reported strong financial performance with a 2.4x quarter-over-quarter revenue increase while reducing operating expenses. The expansion includes support for major languages like Chinese, Hindi, Spanish, and French, positioning Amesite for both B2B and B2C growth in the healthcare documentation sector.

Amesite (NASDAQ: AMST) reported significant growth in Q3/2025, with its AI-powered healthcare app NurseMagicTM generating 2.4x revenue increase compared to Q2/2025. The company achieved balanced revenue distribution between B2B and B2C sales, while successfully reducing operating expenses. Following paid subscription launch in Q2, user growth surged by 1340% in Q3.

The company expanded its B2B offerings with Teams Plus+ and is targeting the substantial U.S. healthcare market, including 16,700 Skilled Nursing and Home Health Care Facilities employing 1.38 million workers, and 8,514 hospice organizations with 407,692 workers. Recent developments include hospice segment expansion, HIPAA compliance implementation, and introduction of a higher-priced B2B tier.

Amesite (NASDAQ: AMST) has successfully launched a new premium service tier called NurseMagic Teams Plus+ in response to growing enterprise demand. The higher-priced tier offers increased capacity and 24/7 access to advanced analytics for business customers who have integrated NurseMagicTM into their workflows.

The company reports strong customer willingness to pay premium prices for increased usage and analytics capabilities. The expansion follows successful adoption across various healthcare roles, including nurses, CNAs, chaplains, and coordinators. The new tier provides real-time insights, productivity metrics, and tools aimed at reducing costs and improving staff retention.

This development comes just 8 months after the B2B solution's public launch and follows recent announcements about HIPAA compliance and expansion into the hospice segment.

Amesite Inc. (NASDAQ: AMST) announced that its NurseMagic™ platform now meets HIPAA requirements for all users, both individual and enterprise. The platform enables healthcare providers to securely store and handle patient information through Business Associate Agreements (BAA).

NurseMagic™, launched in June 2024, has expanded to users across all 50 U.S. States and 21 countries, serving professionals in over 130 different healthcare roles. The platform allows users to integrate documentation with any electronic medical record (EMR) system, leveraging AI capabilities to improve efficiency.

The company reports positive traction in both B2B and B2C sales, with the healthcare software-as-a-service market projected to reach over $90 Billion by 2033 at nearly 11% CAGR.

Amesite (NASDAQ: AMST) announces its resilience against recent U.S. trade tariffs due to its domestic operations structure. The company, which develops AI-powered enterprise solutions, maintains a fully remote U.S.-based workforce and operates without dependence on foreign hardware or suppliers.

The new trade policy implements a 10% tariff on most imports and up to 32% on goods from certain countries. Amesite's cloud-native infrastructure and domestic technology base shield it from these tariff impacts.

The company's NurseMagic™ solution demonstrates significant efficiency gains, reducing charting time by 95% while ensuring audit-ready documentation. Amesite reports increasing enterprise-wide adoption across clinical and non-clinical teams, including social workers, administrators, and aides, driving user growth and revenue expansion.

Amesite (NASDAQ: AMST) announced successful early adoption of its non-clinical caregiver tool in NurseMagic™, an AI-driven solution supporting non-clinical healthcare workers. The expansion targets home health care and skilled nursing segments, effectively increasing its enterprise addressable market by 50%, reaching over 1.5 million non-clinical healthcare support workers in the U.S.

Key achievements include:

• Hospice provider contracts growth of over 3,000% in the last three months
• Contract sizes increase of nearly 1,000%
• Implementation of automated purchase process for faster contract expansion

The NurseMagic™ solution aims to reduce management intervention needs while improving documentation, communication, and patient care. The company's proprietary AI infrastructure is HIPAA-compliant and designed for rapid training and accuracy, with plans to introduce new tools in the coming months based on customer engagement and market needs.